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Processes and interactions in the detection,
evaluation, and management of environmen-
tal threats in communities or public health
can be described from different points of view.
A recent report of the Pew Environmental
Health Commission emphasized the “need of
a modernized public health defense system
that will protect our citizens and their com-
munities from chronic health conditions and
environmental risk” (1). The report focused
on administrative and monetary aspects and
suggested more resources for the public health
practice but did not deal with issues involving
how science and communities interact. A
recent description of modern challenges of
environmental epidemiology emphasizes the
need for a population and ecosystem level.
However, the suggested approach did not
address the interaction of researchers and
communities (2). Within the ﬁeld of environ-
mental research, epidemiologists are at the
forefront of community interaction. When
examining people during data collection, envi-
ronmental epidemiologists learn about their
concerns. Nevertheless, the history of misun-
derstanding and mistreatment of communities
is long (3). This article presents a weak-point
analysis of environmental health research for
outcomes not routinely registered, focusing on
thyroid disorders as one example. The work
attempts to explain why environmental
research for, with, and in communities
requires a more complex scientiﬁc approach.
The weak-point analysis, ranging from mol-
ecular explanations to communication
approaches, is structured in six parts: 
• In an ideal world
• Thyroid disorder: historic and modern
challenges 
• Detection of environmental problems and
community experience with experimental
hypothesis testers
• The juggler and the mechanics
• Beyond mechanistic research: require-
ments for environmental research that
serves public health
• Models for community-oriented environ-
mental approaches.
In an Ideal World
In an ideal world, epidemiology serves public
health through a problem-solving cycle.
Whenever the community, physicians, or sci-
entists identify a health-related issue, epi-
demiology initiates the definition and
quantification of the problem. After priori-
ties have been set and measures conducted to
diminish public health problems, epidemio-
logic work focuses on quantifying potential
results. Finally, new assessments serve as
input for an adapted new round of the
problem-solving cycle. 
In an ideal world, all exposures are
monitored everywhere and all people are
informed in order to make an educated
decision whether to accept or attempt to
reduce exposures. We are, however, far
away from the ideal world. The U.S. General
Accounting Ofﬁce concluded that surveys of
the Department of Health and Human
Services and the U.S. Environmental
Protection Agency have measured about 6%
of approximately 1,400 toxic chemicals. Even
for those chemicals that are measured, infor-
mation is often insufﬁcient to identify smaller
populations at high risk (4).
We use health outcomes to identify expo-
sure, partly because of our distance from a
world with ideal exposure information and
for practical reasons, but primarily because
for rare or unexpected health risks, only an
increased frequency of diseases indicates the
area of concern. In fact, in the last three
decades the identiﬁcation of toxic hazards in
communities and workplaces often stemmed
from lay observations, not from exposure
monitoring or human biomonitoring (3).
Identification of the hazards by lay observa-
tions requires, however, that individuals
notify the association of health effects and
pollutants, community residents share infor-
mation, and community groups organize to
pursue investigations. The limitations of this
process are obvious. Communities at the
lower end of the socioeconomic scale are dis-
advantaged, which can produce environmen-
tal injustice. Modern sociology describes the
capacities of communities to master their
environment as social capital (5,6). Given
that we might have to employ disease to iden-
tify environmental health risk, there are two
alternatives: monitor all diseases and/or
empower communities. 
Ideally, all diseases would be monitored
everywhere. All people would be informed and
subsequently do their best to reduce the bur-
den of diseases and the related critical expo-
sures. An attempt to follow this ideal is
presented by the small area health statistics in
the United Kingdom (7–9) or the proposal of
a nationwide health tracking network in the
United States (1). This common-sense
approach requires that exposure causes mani-
fest diseases, which in turn could be moni-
tored. This limits health statistics to outcomes
such as mortality, cancer, and malformation.
Our knowledge about the distribution of exposures to toxic chemicals in various communities is
limited. Only about 6% of approximately 1,400 toxic chemicals have been identiﬁed in surveys.
Even for those chemicals that are measured, information is often insufﬁcient to identify smaller
populations at high risk. The question is whether information about the distribution of diseases in
communities can help identify environmental risks, indicate areas of concern, and thus substitute
exposure information. Thyroid disorders represent a large group of diseases that cannot be
recorded into registries because of the lack of clear caseness; community-based monitoring of
subtle health effects is needed. Thus, to identify potential health risks in communities,
epidemiologic studies including effect and human exposure monitoring are necessary. However, to
overcome the limitation of nonsystematic case studies, the development of a network of exposed
communities concerned about exposures is proposed. A network would provide assessments of
exposures and health outcomes, with different communities mutually serving as exposed and
control groups. Such a network would foster communication and prevention measures within
communities often left out of the dissemination of information about risks identiﬁed in studies
conducted with residents of these communities. Key words: community, design, environment,
participation, PCBs, risk communication, thyroid, thyroxine, triiodothyronine, TSH. — Environ Health
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This approach may be capable of detecting
disease with a short latency period such as
birth defects (latency period: about 9
months) around chemical waste sites
(10–12). However, this approach is inap-
propriate for many subclinical effects such
as minor reductions of intelligence, alter-
ations of human reproduction, and subtle
effects on the thyroid. A second require-
ment is that manifestation of the disease
occur shortly after exposure. When relying
on small area health statistics and related
exposures, diseases with long latency periods
can hardly be attributed to past exposures. 
Questions posed by exposed communities
or public health are far more complex.
Regarding thyroid disorders, there are at least
four questions from potentially exposed and
educated communities:
• Are we exposed to chemicals that affect
the thyroid as well as thyroid hormones?
• Will we develop manifest thyroid disorders
after experiencing endocrine disruptions?
• Will our children develop thyroid disor-
ders because of exposure in early life?
• Will our children develop mental delays if
exposed to endocrine disruption in utero
or in childhood?
Thyroid Disorder: Historic and
Modern Challenges 
These questions may be exemplified with a
historic example (simple exposure and etiol-
ogy) and with one actual example that chal-
lenges the simple assessment of health risks
(complex etiology). 
The Historic Example 
One disorder of the thyroid gland, thyroid
enlargements (goiters), was recognized around
3000 BC. For centuries, endemic goiter had
been detected in mountainous districts. As
early as the beginning of the 19th century,
goiters were attributed to insufﬁcient iodine in
the daily diet. Additionally, lack of iodine in
pregnancy (gestational weeks 12–30) was
recognized as a cause of endemic cretinism.
A major outcome of maternal goiter was
endemic cretinism in the offspring. A survey
carried out under Napoleon’s order in the
year 1810, in what is now the Swiss canton of
Valais, revealed 4,000 cretins among 70,000
inhabitants (13). Thirty percent of young
men were afflicted with a large goiter and
were thus unfit for military service. Deaf
mutism (the inability to speak due to congen-
ital or early affliction of profound deafness)
was associated with the prevalence of goiter
and in the survey served as a marker for cre-
tinism, which was variable in its manifesta-
tions and therefore hard to deﬁne. 
It took centuries to identify the environ-
mental cause. In the 19th century, even
though the lack of iodine had not yet been
identified, sea algal extracts, rich in iodine,
were used to treat the disease (14).
Iodinization of salt was then introduced in
1922 in Switzerland. No new endemic cretins
born after 1930 have been identiﬁed. Goiter
disappeared rapidly in newborns and school-
children, more slowly in army recruits, and
incompletely in elderly adults (13).
Historically, for goiter, the health problem-
solving cycle was completed. It is clearly a
public health success story. Thyroid diseases
and cretins could be prevented, although not
all mechanisms were investigated and tested.
This example, however, describes a simple
relation, which might explain its success.
First, for the regions involved, iodine defi-
ciency was the single major cause. Second, no
community involvement was required to
understand routes of exposure, the develop-
ment of the disease, or the implementation of
preventive measures (iodinization).
The Modern Example: Complex Effects
of Polyhalogenated Dioxin, Furans, and
Biphenyls on the Thyroid
The potential impact of halogenated organic
compounds (HOCs) such as dioxins/furans
and biphenyls on the thyroid gland was ﬁrst
detected in wild animals (15,16). The effects
seem less dramatic but more complex in com-
parison with those caused by the lack of
iodine. Nevertheless, as with insufficient
iodine, there may be definite direct and
indirect effects on the fetus, mediated by
maternal exposures. 
Every cell in the body depends on the
thyroid hormones thyroxine (T4) and
triiodothyronine (T3) for regulation of
metabolism. The normal thyroid gland pro-
duces about 80% T4 and about 20% T3.
The latter possesses about 4 times the hor-
mone potency of T4. The thyroid gland is
under the control of the pituitary gland.
When the level of thyroid hormones (T3,
T4) drops too low, the pituitary gland pro-
duces thyroid-stimulating hormone (TSH),
which stimulates the thyroid gland to pro-
duce more hormones (feedback). Under the
influence of TSH, the thyroid gland manu-
factures and secretes T3 and T4, thereby rais-
ing their blood levels. Thyroid hormones
(T3, T4) are transported in the blood by pro-
teins, T4-binding globulin (TBG), also
called transthyretin or T4-binding prealbu-
min. Unbound T3 and T4 (free T3, T4) are
metabolically active. Thus, an alteration of
thyroid hormones can result from a change
in concentration of the transport proteins
and from competitive binding of xenobiotics
to these proteins.
For the fetus and in childhood, thyroid
hormones are essential for the development
of brain function and the growth of cells.
Deficiency of thyroid hormones can subse-
quently result in a serious delay in neuro-
logic development. However, the effects of
minor reductions have not yet been clearly
established (17–20). 
Chemically, HOCs such as polychlori-
nated or polybrominated biphenyls (PCBs or
PBBs, respectively) and dioxin show chemical
structure similarities to T3 or T4 (21). This
fact supports the assumption that HOCs
might bind to structures normally employed
by T3 or T4. There are ﬁve targets for thyroid
hormone metabolism: a) thyroid gland: pro-
duction of T3 and T4; b) transport of T3 and
T4; c) metabolism of T3 and T4 with either
deiodination of T4 (activation to T3), produc-
tion of reverse T3 or T2 (inactivation), or glu-
curonidation and increased excretion of T4;
d) central effect: feedback and production of
TSH, and e) blockage of the T3 and T4 cell
receptors (e.g., brain cells) (22–29).
A literature search identiﬁed 13 reports on
HOCs and thyroid disorders (Table 1). Six of
the 13 studies identified a significant TSH
increase due to HOCs, 4 an HOC-related
decrease of T3 or T4, and the other 3 an
HOC-related increase of T3 and T4.
In Slovakia, although no association was
found in T4 or TSH levels (Table 1), an
increased thyroid volume was detected in 238
workers in a factory that had previously pro-
duced PCBs and in 454 adolescents from the
surrounding area (polluted by PCBs), com-
pared with controls (572 adults and 965 ado-
lescents) (Table 2). Thyroid volume was
enlarged predominantly in adolescents who
were born during the period of maximal pol-
lution. The Slovakian study emphasized the
risk of early childhood exposures (30). In
addition, an environmental epidemiology
study in Hamburg, Germany, indicated that
children who moved into a development area
contaminated with polychlorinated dibenzo-
p-dioxins (PCDDs), polychlorinated dibenzo-
furans (PCDFs), arsenic, lead, cadmium, and
mercury early in life showed significantly
increased thyroid volumes in adulthood
(Table 2) (31). 
The findings in Table 1 provide modest
evidence that exposure to PCBs and PBBs
may affect the thyroid function. Inconsistent
ﬁndings might be explained by confounding
due to autoimmune reactions. Reaction to
thyroid antibodies, in Graves disease, for
example, is characterized by an overproduc-
tion of thyroid hormones. The mechanism
involves the binding of autoantibodies to the
TSH receptor, activating adenylate cyclase,
and stimulating an unregulated synthesis of
T4 and T3. In Hashimoto thyroiditis,
autoantibodies and sensitized T lympho-
cytes, delayed-type hypersensitivity (TDTH)
cells specific for thyroid antigens are pro-
duced, unleashing a DTH response of lym-
phocytes, macrophages, and plasma cells inExposures and thyroid disorders
the thyroid. Hypothyroidism results when
autoantibodies bind to the proteins thy-
roglobulin (Tg) and thyroid peroxidase
(TPO), thereby blocking the uptake of
iodine required for the normal production
of thyroid hormones. There is evidence that
HOCs are associated with thyroid antibod-
ies (Table 3). Tg antibodies were detected in
8 (19.5%) of 41 Yusho patients with PCB
concentrations higher than 3.0 ppb and in
only 1 (2.5%) of 40 patients with PCB con-
centrations lower than 2.9 ppb (32).
Residents living in a contaminated develop-
ment area had an increased prevalence of
antibodies against human TPO (TPO titers
>70 U/L) compared with residents of two
areas with less or no pollution (19.1% com-
pared with 10 and 12.6%) (33). In the
Slovakian study of 190 female workers in a
factory that previously produced PCBs, a
significantly increased prevalence of TPO
(28%) was detected compared with 20% in
482 controls (30). There was also a higher
prevalence of Tg antibodies in women
(21%) and antibodies against the TSH
receptor in men and women (10%). 
Potential overproduction of T3 and T4 as
a reaction to autoantibodies, however, is just
the opposite of what is predicted as a result of
the endocrine reaction to PCBs. Some of the
studies included in Table 1 identiﬁed a higher
prevalence of antibodies against TPO and Tg
and no increase of TSH (30) or no PCB
effect on thyroid hormones (32). It is possible
that these negative ﬁndings result from mix-
ing  endocrinologic and autoimmune effects
(PCBs → T4↓ and thus TSH↑ versus
PCBs→ autoantibodies → T4↑). Thus,
studies that identify specific effects are
required to provide an unconfounded assess-
ment of the HOC-thyroid association.
Research results are inconclusive. However,
adverse effects cannot be excluded, as the
studies did not distinguish endocrine and
immune effects and different time windows
of exposure (childhood vs adulthood). One
reason for the insufficient state is that
studies were not broad enough and did not
include all markers needed to evaluate
potential associations between HOC in the
environment and effects on the thyroid
gland. Another reason is that most studies
were not committed to serve public health
but to test some hypotheses. Community
participation, for example, in the study with
the PBB exposure (Table 1), would have
caused researchers to contribute greater
efforts toward understanding the PBB-
hypothyroidism association, as communities
and exposed individuals need the most com-
plete information to manage the disease and
to prevent long-term effects. For instance, in
the study with residents who lived on the
waste site (Table 3), it was the residents and
one of their family doctors who requested an
investigation of thyroid antibodies, as several
residents claimed to have increased levels of
antibodies. 
Thus, to make the thyroid–HOC associa-
tions more complex, we have to add another
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Table 1. Effect of PCBs/PBBs on thyroid hormones.
Author, year (ref) Exposure TSH (thyreotropin) T4 T3 n Population, gender, age
Hagmar et al., 2001 (59) PCB153 blood concentration — (↓) ↓ (PCB153) 182 Fishermen’s wives, ﬁsh consumption 
Longnecker et al., 2000 (60) PCBs (human milk) — — — Newborns
Calvert et al., 1999 (61) TCDD blood concentration ↑ (Total*TBG) 541 Workers (≈20–70 years)
Langer et al., 1998 (30) PCB workplace/environmental  — — — Workers and residents (22–68 
exposure years), 17-year-old adolescents 
Osius et al., 1999 (53) PCBs and congeners (blood  ↑ (PCB118) — ↓ (PCB153, 320  Children (7–10 years)
concentration) 180, 187)
Nagayama et al., 1998 (62) PCDDs, PCDFs, and PCBs (human milk) ↓↓ 36 Infants (1 year)
Tsuji et al., 1997 (32) PCB blood concentration (28  — — — 81 Yusho patients (≈30–80 years)
years after exposure)
Koopmann-Esseboom et al., 1994  PCBs (human milk) ↑↓ 78 Infants (second week) 
(63), Sauer et al., 1994 (64)
Pluim et al., 1993 (65) PCDDs and PCDFs (human milk) ↑ (11 weeks) ↑ (1 week: T4)3 8 Infants (1 and 11 weeks) 
Karmaus et al., 1990 (66) PCDD and PCDF indoor concen- ↑ —— 400 Teachers (20–60 years)
trations, wood preservatives
Karmaus et al., 1990 (66) PCDD and PCDF indoor concen- ↑ —— 625 Children (3–20 years)
trations, wood preservatives
Murai et al., 1987 (67) PCB blood concentration (16  — ↑↑ 123 Yusho patients (≈20–80 years)
years after exposure)
Bahn et al., 1980 (36) PBB workplace exposure ↑ 124 Workers, male, middle-age 
Abbreviations: ↑, increase; ↓, decrease; —, no association; ( ), marginal signiﬁcance.
Table 3. Effect of HOCs on thyroid antibodies.
Proportion with antibodies
Tg TPO Comparison
Author, year (ref) antibodies (%) antibodies (%) group(s) (%) n Population, gender, age
Osius et al., 1997 (33) 19.1 10, 12.6 619 Residents, waste site, 
(PCDDs, PCDFs, arsenic, 
cadmium, lead, mercury)
Langer et al., 1998 (30)2 82 0 672 Male workers
21.3 14.6 511 Male workers (31–60 years)
Tsuji et al., 1997 (32) 19.5 2.5 81 Yusho patients (30–80 years)
Table 2. Effect of HOCs on thyroid volume.
Proportion with increase in thyroid volume
Author, year (ref) Exposed groups Comparison group n Population
Karmaus and Osius, 1995 (31)  Increase with decreasing  Other age  771 Residents, waste site
age of ﬁrst exposure groups
Langer et al., 1998 (30) Work exposure  2.3% 457 Workers
21–35 years: 10.2%
11–20 years: 9.6%Karmaus
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question to the four questions raised by
communities (see above): Are contradictory
results (Table 1) due to a different involvement
of autoimmune and endocrine pathogeneses? 
These five questions are highly inter-
dependent, similar to ﬁve balls juggled in the
air at the same time. The state of the art and
also educated communities thus pose complex
questions and deserve the best quality answers.
However, the monitoring systems focused on
manifest disorders that can be registered, such
as birth defects and cancer, will not be able to
answer these questions. Thyroid disorders are
thus an example of a large group of diseases
that includes, for example, infertility, minor
reduction of intelligence, asthma, and allergic
manifestation. They may be caused by envi-
ronmental contaminants and detected by con-
cerned communities, but they cannot be
detected through existing disease registries, as
these diseases do not regularly develop into
definite cases. Nevertheless, these disorders
affect the public health. 
If monitoring of registered diseases does
not work, what are alternative avenues to
detect diseases, conduct investigations, and
inform the public about potential environ-
mental risks? The next three sections are
devoted to this question. First, we describe
experiences of communities with experimen-
tal hypothesis research; second, the experience
of environmental epidemiologists with experi-
mentally oriented funding is reported; and





New kinds of exposures, sometimes detected
by chance, attract research. One example is
the PBB exposure in Michigan. St. Louis,
Michigan, is a low-income community that
was the site of Michigan Chemical (A.K.A.
Velsicol) from 1935 to its closing in 1978.
The production included inorganic products
(magnesium oxide), rare earths, and a variety
of halogenated organic products such as
1,1,1-trichloro-2,2-bis(p-chlorophenyl)ethane
(DDT), and starting in 1971, the fire retar-
dant PBB. In 1973, PBB was shipped instead
of magnesium oxide for use in cattle feed, an
error that set in motion one of the most noto-
rious environmental disasters on record. In
1974, deaths of cattle led to the discovery of
the contamination of cattle and agricultural
products (34). DDT levels in the ground
around the plant were as high as 44,000 ppm
(maximum safe level: 5 ppm). Fish from the
Pine River were highly contaminated with
PBBs and DDT. 
Researchers from a variety of institutions
were attracted by these rare exposures,
collected information and blood, tested
hypotheses, and published their results
(34–41) but did not communicate their ﬁnd-
ings to the communities. Additionally,
researchers focused on single health outcomes
(e.g., hypothyroidism, impaired immune
function, developmental impairments,
cancer) but did not address the complex sce-
nario or the concerns of the citizens. In most
investigations, but not all, participants were
informed about their individual ﬁndings, but
the exposed communities were not informed
of overall results. Thus, after 25 years, unan-
swered questions remain regarding issues of
whether residents could safely live close to the
former production sites, or if former workers
would be more likely to experience adverse
health outcomes in the future. The public did
not receive high-quality information. On the
contrary, the exposed community experi-
enced disappointment with hypothesis testers.
The lack of risk communication produced
resentment against some central research
administration and increased reluctance to
participate in further studies. These feelings
of alienation revealed a structural deficit:
hypothesis-testing research is not sufﬁciently
connected to public health (Table 4). The
hypothesis-testing approach did not empower
the community to achieve the best informa-
tion but instead took the power away.
The example reveals two dilemmas with
this type of mechanistic hypotheses testing in a
public health setting. A ﬁrst dilemma is that
application of an experimental approach to
public health research has limitations. In a
mechanistic experimental setting, research may
focus on one exposure and one outcome, keep-
ing all other factors constant. Regarding expo-
sure, epidemiologic research cannot provide
the best quality information if it is limited to
focusing on a single risk factor [for instance,
1,1,1-trichloro-2,2-bis(p-chlorophenyl)ethyl-
ene (DDE)] without accounting for the possi-
bility of others (PCBs and PBBs). Findings
may show a signiﬁcant association of a particu-
lar health outcome with DDE, but in reality
the risk was not truly associated with DDE but
with PBBs or PCBs. Such spurious associa-
tions can be minimized by carefully designed
studies that need to be sufficiently broad to
avoid overly narrow exposure assessments. In
addition, regarding the assessment of health
outcomes in a public health setting, epidemio-
logic research cannot provide the best informa-
tion if restricted to only one health outcome. It
should be the aim for any research project to
provide beneficence to individual subjects,
communities, and society as a whole. This eth-
ical responsibility entails providing the maxi-
mal possible benefit, which requires using a
broader and more comprehensive approach.
The second dilemma is that mechanistic
hypothesis-testing research often does not ﬁt
the needs of individual communities and
public health. Hypothesis-testing research is
often focused on speciﬁc scientiﬁc questions.
Its objective is publication of findings, a
necessity for the researcher. However, there
are no incentives for scientists to engage in
risk communication or community participa-
tion. Communities have broader questions
regarding their health. 
Environmental epidemiology is at the
forefront of new research strategies. An envi-
ronmental epidemiologist has to consider a
complex scientiﬁc setting as well as collabora-
tion with communities. Considering these
requirements, an environmental epidemiolo-
gist is like a juggler who knows how to juggle
four balls effectively. At the request of the
community, however, the juggler has to add a
ball and keep ﬁve balls in the air at the same
time. Thus, the epidemiologist needs funding
to prove that he can juggle ﬁve balls. 
The Juggler and the
Mechanics
To obtain funding, a juggler who can keep
four balls in the air at the same time
approaches a review board of three mechan-
ics for funding to prove he can juggle five
balls. He wants to study  the special tech-
niques  required to keep the balls in the air.
He suggests scientific models and methods
to approach this complex field as well as
ways of communication with the citizens.
The first mechanic suggests that the juggler
focus his research; he should study the
mechanics of one ball at a time. The second
mechanic agrees and explains that in his lab-
oratory ﬁve related experiments could not be
run simultaneously and that there is no way
to evaluate the meta-mechanics of five balls
in the air. In addition, the third mechanic
decides that the juggler’s approach is much
too ambitious. The third mechanic suggests
that the juggler not communicate with the
communities before his results are conﬁrmed
by other studies. Funding is denied. The
juggler is advised to focus on a specific
hypothesis in experimental research, focus
on science, and stay away from community
involvement. 
Table 4. The need to bridge community-based research and hypothesis testing.
Community-based public health research Hypothesis-testing research
Multiple focuses (health outcomes)  Focused (one outcome)
Multiple exposures Preferably a single exposure




That Serves Public Health
There is no doubt that experimental designs
have their strengths. However, when applying
a series of oversimpliﬁed designs to a complex
problem, the disadvantages will outweigh the
advantages such that public health concerns
cannot be addressed properly. Hypothesis-test-
ing designs attempt to mimic experimental
approaches, even in public health settings.
Hypothesis-testing research often focuses on
one outcome, preferably a single exposure, and
has one main goal, namely, scientiﬁc publica-
tions. Community-based research has to con-
sider real-life situations with multiple focuses
(outcomes) and multiple exposures. The guid-
ing objectives are risk communication and the
development of strategies for problem solving
(Table 5). As stressed in environmental epi-
demiology textbooks, public health research
requires a long-term involvement and a com-
promise between scientiﬁc objectives and com-
munity participation that will alter the rigid
scientific model. This approach has not yet
been accepted by some funding agencies that
ask for nonﬂexible mechanistic approaches.
However, there are alternative and more
efﬁcient models in public health science than
mechanistic hypothesis testing. Modern epi-
demiology can incorporate complex scenar-
ios, increase generalizability, and address
public health concerns when not restricted to
mechanistic hypothesis testing. There should





To overcome these limitations, research and
state agencies, communities, concerned citi-
zens, and nongovernmental organizations
need to integrate their environmental health
research efforts. Because our knowledge is
limited about the distribution of exposures to
chemicals in communities and their associa-
tion to health, we have to integrate human
biomonitoring and health monitoring. Instead
of conducting the three aspects of environ-
mental health research separately, namely,
human exposure monitoring (biomonitoring),
research into the association of exposures and
health effects, and risk communication with
community, we should use our resources more
carefully, with better planning, and foster the
collaboration of different research groups,
such as those in clinical trials, for the common
good of public health. 
One suggestion is the formation of a
network of communities concerned about
exposures. In addition to the common repre-
sentative national sampling, the network could
provide assessments of exposures and health
outcomes, with different communities mutu-
ally serving as exposed and control groups. As
research would directly address community
concerns, such a network would foster com-
munity participation and convey risk commu-
nications (Table 5) (42). Communities beneﬁt
as they gain information on regional health
risks. Research beneﬁts when a set of multiple
communities with different exposures, partici-
pating in such a network, provides access to
study groups, collects a complex range of expo-
sures, and allows the contrasting of a variety of
health effects with different exposures and
varying exposure levels. For example, of 10
participating communities, mercury may be
elevated in 3; however, we determine the back-
ground levels from the other 7 and can thus
investigate the extent of the mercury problem.
We may have a complex exposure of mercury
and PCBs in 2 communities and can investi-
gate whether markers of effects are associated
with mercury, PCBs, or both.
To show that rudimentary networks exist
and that compromises between concerned
communities and research can be guided,
some examples are listed below.
Incomplete, Post-hoc Collaboration 
on Exposures 
Regarding human exposure monitoring,
studies in several sites in various areas of
Germany have collected information on
exposure to PCBs and metals. Data about
PCBs from 11 individual studies in different
communities were gathered by a federal
Human Biomonitoring Commission that
provided suggestions for background levels
(43). An even earlier initiation of the collabo-
ration between the different studies may have
contributed to a larger basis of comparison.
However, collaboration in environmental epi-
demiology (as, for example, in multicenter
clinical studies) is very rudimentary. Another
example is the comparison of PCB concentra-
tions in breast milk samples collected in sev-
eral studies over a long period. Several
laboratories collaborated and provided results
on differences between countries and on
trends in recent decades (44,45). Concerned
communities use such information to identify
whether their potential exposure is higher
than expected.
Large-Scale Collaboration with and
without Community Participation 
The International Study on Asthma and
Allergy in Childhood managed to have
researchers from 56 countries around the
world (156 collaborating centers) conduct
identical investigations (46). These results
provided important information about the
variation of a disease that could not other-
wise have been achieved. Additionally, a
great variety of sites also collected informa-
tion on air pollution or other specific expo-
sures (47–49). The network of Healthy
Cities, supported by the World Health
Organization, is an example for local com-
munity participation and for collaboration
of different communities that have to find
solutions for identical local problems (e.g.,
automobile traffic and the threat to
children’s health) (50).
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Table 5. Hypothesis testing of the exposure and disease association versus understanding and community participation. 
Isolated hypothesis-testing research world Community-participating research world
Test if E–D association is true regardless of the speciﬁc community life styles.  Focus on occurrence of exposures and diseases in community life.
Test the E–D association. Understand the E–D association.
Assume that it is sufﬁcient to know initial exposure data to explain   Understand why individuals are exposed within the community and the routes of exposure. 
subsequent diseases. Collect information about paths of exposure (E1 → E2). 
Observe a population over a long or short period, with short phases of  Observe a population over a long period with repeated measurements. Enlist community 
individual involvement, typically during data collection. involvement and participation.
Analyze the data on the E–D association. Analyze the E1 → E2 → D1 → D2 → D3 associations. Understand the underlying molecular 
and biologic processes and the different options to reduce the risk of early and ﬁnal stages 
in the pathogenesis. Communicate ﬁndings and prevention strategies to the community.
Publish the results about the E–D association. Publish the results within the scientiﬁc world and for the community. 
Assume that knowledge on the E–D association is sufﬁcient to change  The mechanism of E–D need not be entirely clear to prevent adverse disease outcomes. 
public health. Participation of community groups is required to develop prevention strategies.
Abbreviations: D, disease; E, exposure.Karmaus
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Small-Scale Collaboration with
Community Participation 
Communities in Hesse, Germany, requested
and participated in a study on a toxic waste
incinerator. The study also included commu-
nities that were not exposed to the toxic
waste incinerator and gathered a great variety
of exposure and health data in children
(51–56). The data included questionnaire
information, biomonitoring of metals and
organochlorine compounds, laboratory data
on thyroid hormones, humoral and cellular
immune responses, lung function data, deter-
mination of air pollution, etc. Most of the
information was repeated in two or three fol-
low-up surveys. This richness of information
is unusual for some funding agencies and a
threat to reviewers who prefer to focus on a
single issue. However, a more complex
approach with integration of molecular,
social, and communication issues is not an
impossible mission. Exposed and non-
exposed communities profited from the
depth of the investigations and learned about
exposure risks to children in their resident
areas (e.g., lead from water pipes). As investi-
gations were harmonized with other studies,
the project also contributed to the collection
of national reference data (43). The study
also achieved openness, a goal proposed in
environmental epidemiology (57), as repre-
sentatives of concerned citizens, the local
health department, and physicians participat-
ing in the project requested additional and
detailed information about methods and
results. In effect, communities were able to
control the project and trusted its risk assess-
ment. Scientifically, the richness of the data
was a treasure for etiologic research. 
Compromises between Communities
and Science: The Leapfrog Procedure
Researchers have to compromise between
scientific and community goals. In the last
example (toxic waste incinerator), researchers
and communities decided not to test all possi-
ble or plausible hypotheses between exposures
and health markers, but rather to apply a
leapfrog procedure. The procedure requires
that both exposures and health markers are
increased in the same communities before the
association between the two dimensions is
investigated based upon individual observa-
tions. This was the case for PCBs and thyroid
hormones, for example. After having demon-
strated that the level of PCBs was signifi-
cantly higher for children of the toxic waste
site area (51) and that the levels of thyroid
hormones were lower in this area (52), the
association of PCBs and thyroid hormones
was investigated (53). 
It is suggested that such networks, as
well as other collaborative projects, need
scientific steering groups. Second, such
networks require local collaboration with the
communities. Researchers have to provide
information on their methods and findings.
Citizens have the right to request alternative
approaches. The collaboration may be
arranged as round-table meetings of
researchers, local health authorities, and
concerned citizens. A third component is
meetings of representatives of the communi-
ties. The communities should exchange their
experiences in order to improve the collabo-
ration and the impact of the research on
public health.
Regarding the costs, there are hundreds of
disconnected studies funded by different
agencies on different environmental topics.
The major costs in epidemiologic projects
involve recruitment and participation in the
study. If each study would add some research
modules to its protocol, we would gain
important information for different popula-
tions; ﬁrst, on the distribution of a variety of
exposures; and second, on the distribution of
health outcomes that do not ﬁt into adminis-
trative disease registration. Scientifically, we
would gain a rich data set and could test a
variety of exposure–health associations. The
network of exposed communities, therefore,
would require collaboration but ultimately
would reduce costs. 
Imagine that the juggler who approached
the review board is not asked to focus on one
experimental question that may provide a few
mechanical explanations but is asked to carry
out some additional work for the common
good of public health. Protocols and funding
would be provided for his research questions
and for the additional work. He is, however,
requested to participate in a network of
research with exposed communities.
In summary, a network of communities
can provide an epidemiologic laboratory.
Research involving diseases with complex eti-
ologies and pathogeneses requires not only
intricate molecular methods but also
increased community participation. There
are three reasons for these needs: to conduct
long-term community studies, to understand
the environmental condition, and to lay
groundwork for prevention. Community-
based research can integrate processes that
occur on a molecular, individual, and com-
munity level. Information on real life is nec-
essary to gain a better understanding of
exposures (use of pesticides, trafﬁc, etc.) and
how to prevent diseases. Basically, the net-
work can integrate exposure assessment,
human biomonitoring, and effect monitor-
ing on a local/community level. 
Thus, to advance our understanding we
must bridge hypothesis-oriented research and
community-oriented approaches (Table 4).
The Ottawa Charter for Health Promotion
has stated this succinctly: 
Health promotion works through concrete
and effective community action in setting
priorities, making decisions, planning
strategies and implementing them to
achieve better health. At the heart of this
process is the empowerment of communi-
ties—their ownership and control of their
own endeavors and destinies. Community
development draws on existing human
and material resources in the community
to enhance self-help and social support,
and to develop flexible systems for
strengthening public participation in the
direction of health matters. This requires
full and continuous access to information,
learning opportunities for health, as well
as funding support. (58) 
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